<DOC>
	<DOC>NCT01634321</DOC>
	<brief_summary>The purpose of this Clinical Trial was to Evaluate the Efficacy and Safety of Luphere Depot Inj. 3.75mg(Leuprolide acetate 3.75mg) in patients with precocious puberty.</brief_summary>
	<brief_title>The Clinical Trial to Evaluate the Efficacy and Safety of Luphere Depot Inj. 3.75mg(Leuprolide Acetate 3.75mg) in Patients With Precocious Puberty</brief_title>
	<detailed_description />
	<mesh_term>Puberty, Precocious</mesh_term>
	<mesh_term>Leuprolide</mesh_term>
	<criteria>4~8 years &amp; tanner stage â‰¥ 2 Previous treatment with GnRH analog therapy</criteria>
	<gender>All</gender>
	<minimum_age>4 Years</minimum_age>
	<maximum_age>9 Years</maximum_age>
	<verification_date>August 2014</verification_date>
</DOC>